Clinical Trial Update: A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD [Phase 1, Phase 2]

View source ↗

Summary

Phase 1b/2a open-label study in adults with Pi*ZZ Alpha-1 Antitrypsin Deficiency is active/not recruiting, sponsored by Wave Life Sciences.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Snippet

Sponsor: Wave Life Sciences Ltd. | Conditions: Alpha-1 Antitrypsin Deficiency | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING